You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 19, 2024

ATORVASTATIN CALCIUM Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Atorvastatin Calcium, and what generic alternatives are available?

Atorvastatin Calcium is a drug marketed by Accord Hlthcare, ACI, Agnitio, Alkem Labs Ltd, Anbison Lab, Apotex Inc, Biocon Pharma, Cadila Pharms Ltd, Dr Reddys, Dr Reddys Labs Ltd, Graviti Pharms, Hetero Labs Ltd V, Invagen Pharms, Lannett Co Inc, Laurus, Lepu Pharm, Lupin Ltd, Mankind Pharma, Micro Labs Ltd India, MSN, Mylan Pharms Inc, Perrigo R And D, Sandoz Inc, Sciegen Pharms Inc, Sun Pharm Inds Ltd, Teva Pharms, Teva Pharms Usa, Umedica, and Zydus Pharms. and is included in thirty NDAs.

The generic ingredient in ATORVASTATIN CALCIUM is atorvastatin calcium. There are sixty-two drug master file entries for this compound. Sixty-two suppliers are listed for this compound. Additional details are available on the atorvastatin calcium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Atorvastatin Calcium

A generic version of ATORVASTATIN CALCIUM was approved as atorvastatin calcium by SUN PHARM INDS LTD on November 30th, 2011.

  Try a Trial

Drug patent expirations by year for ATORVASTATIN CALCIUM
Drug Sales Revenue Trends for ATORVASTATIN CALCIUM

See drug sales revenues for ATORVASTATIN CALCIUM

Recent Clinical Trials for ATORVASTATIN CALCIUM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
United States Department of DefensePhase 2
University of California, San FranciscoPhase 2
Himayat UllahN/A

See all ATORVASTATIN CALCIUM clinical trials

Pharmacology for ATORVASTATIN CALCIUM
Medical Subject Heading (MeSH) Categories for ATORVASTATIN CALCIUM
Anatomical Therapeutic Chemical (ATC) Classes for ATORVASTATIN CALCIUM

US Patents and Regulatory Information for ATORVASTATIN CALCIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mankind Pharma ATORVASTATIN CALCIUM atorvastatin calcium TABLET;ORAL 217081-004 Jan 5, 2024 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Teva Pharms ATORVASTATIN CALCIUM atorvastatin calcium TABLET;ORAL 078773-003 May 29, 2012 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Graviti Pharms ATORVASTATIN CALCIUM atorvastatin calcium TABLET;ORAL 209912-001 Jun 18, 2018 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.